former Chief Medical and Regulatory Affairs Officer · Coherus Oncology, Inc. (CHRS)

Darlene Horton

FY2019 is the first fiscal year CompBrief holds for Darlene Horton as a named executive officer of Coherus Oncology; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2019

$3,629,789

Salary $304,111Stock awards $0Bonus $75,000

2nd of 5 named executive officers at Coherus Oncology by FY2019 total.

5 named officers on file for Coherus Oncology, FY2019

Darlene Horton’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 2 equity grants, each cited to its filing
  • CHRS’s disclosed peer group of 21 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Coherus Oncology’s whole pay program stands against its peers

  • Coherus Oncology’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CHRS→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 6, 2020 (DEF 14A).

Free

Get Darlene Horton’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Darlene Horton compensation by year

Coherus Oncology Summary Compensation Table · the one fiscal year held
In US dollars, as Coherus Oncology reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019
Salary$304,111
Bonus$75,000
Stock awards$0
Option awards$2,765,938
Non-equity incentive$0
Pension and deferred compensation$0
All other$484,740
Total$3,629,789

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Coherus Oncology, Inc. DEF 14A filed April 6, 2020, accession 0001564590-20-015549, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Coherus Oncology, Inc. filed document, accession 0001564590-20-015549. Every figure is read from that document and cited to the page and table it appears in. Filed April 6, 2020.

Coherus Oncology’s named executive officers, FY2019

as the company reported each
Named executive officerRoleFY2019 total
Dennis LanfearPresident, Chief Executive Officer and Chairman of the Board of Directors$5,361,707
Darlene Horton · this pageformer Chief Medical and Regulatory Affairs Officer$3,629,789
Jean-Frédéric ViretFormer Chief Financial Officer$1,829,591
Vincent AnicettiChief Operating Officer$1,810,841
Vladimir VexlerChief Scientific Officer$1,757,229

The full Coherus Oncology compensation record

free company brief

This page is one person within Coherus Oncology's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Coherus Oncology proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Coherus Oncology's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Darlene Horton's compensation dossier · One-time report. No refunds.